➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Medtronic
McKesson
Moodys

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,586,010


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,586,010
Title:Automatic injector with needle cover
Abstract: An auto-injector automatically dispenses a predetermined dose of medicament upon activation. The auto-injector includes a needle cover operative to engage an injection site and activate the injector. The needle cover is configured to move from a locked retracted position prior to a medicament dispensing operation to a locked extended position after the medicament dispensing operation. The non-removable needle cover prevents contact with the needle both before and after the medicament dispensing operation.
Inventor(s): Mesa; C. Michael (Boyds, MD), Tomellini; Dalita Rosemarie (Rehoboth, MA), Bremley; Mark Bumb (Edwardsville, IL), Raven; Sophie Rebecca (Swavesey, GB), Murphy; Martin Joseph (Letchworth Garden City, IE), Rochford; Craig Malcolm (Andover, GB), Kirkwood; Stephen Philip (Haynes, GB)
Assignee: Meridian Medical Technologies, Inc. (Columbia, MD)
Application Number:13/788,509
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,586,010
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 9,586,010

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Speciality Lp EPIPEN epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 019430-001 Dec 22, 1987 AB RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Mylan Speciality Lp EPIPEN JR. epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 019430-002 Dec 22, 1987 AB RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,586,010

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005271355 ⤷  Free Forever Trial
Australia 2010201665 ⤷  Free Forever Trial
Australia 2013222015 ⤷  Free Forever Trial
Canada 2576776 ⤷  Free Forever Trial
Canada 2683253 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKinsey
Colorcon
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.